Overview of methods used in treating excessive hair loss in humansJoanna Kieraś 1/, Martyna Kieraś 2/, Aneta Sitek 3/, Bogusław Antoszewski 4/ 1/ Doktorantka Kliniki Chirurgii Plastycznej, Rekonstrukcyjnej i Estetycznej Uniwersytetu Medycznego w Łodzi 2/ Studentka Uniwersytetu Medycznego w Łodzi 3/ Katedra Antropologii, Wydział Biologii i Ochrony Środowiska, Uniwersytet Łódzki 4/ Klinika Chirurgii Plastycznej, Rekonstrukcyjnej i Estetycznej Uniwersytetu Medycznego w Łodzi Summary Excessive hair loss is a common dermatological and psychosocial problem, whose prevalence increases with population aging and rising environmental stress. The most frequent types of alopecia include androgenetic alopecia (AGA), alopecia areata (AA), telogen effluvium (TE), and chronic inflammatory scalp conditions (PSZSG). In response to growing therapeutic demand, numerous treatment methods have been developed, differing in mechanisms of action, effectiveness, and safety. These include pharmacological therapies (topical and systemic), procedural techniques, and supportive methods. Pharmacotherapy involves agents such as minoxidil, DHT inhibitors, corticosteroids, and immunomodulators. Procedural treatments include scalp peels, oxygen infusion therapy, carboxytherapy, microneedling and mesotherapy, platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and low-level laser therapy (LLLT). Supportive methods encompass dermocosmetics, scalp massage, and supplementation of micronutrient deficiencies. Increasing evidence suggests that combination therapies often yield better clinical outcomes than monotherapies. Analysis of available treatment strategies, however, highlights the lack of standardized protocols for evaluating efficacy and safety, which hinders the development of optimal therapeutic algorithms. This emphasizes the need for individualized treatment approaches and further well-designed studies to identify factors influencing therapeutic response and improve treatment outcomes in alopecia. Key words: alopecia, therapy, efficacy |